Fertility Test Market Report and Forecast 2025-2034

The global fertility test market size was valued at USD 583.90 Million in 2024, driven by the increasing prevalence of infertility across the globe. The market is expected to grow at a CAGR of 7.60% during the forecast period of 2025-2034, with the values likely to rise from USD 628 Million in 2025 to USD 1.21 billion by 2034.

Fertility Test: Introduction

Fertility testing is used to identify the issues that might be preventing a couple from conceiving. Fertility tests are available for males as well as females. It constitutes blood tests, pelvic examination, seme analysis, post-coital tests, laparoscopy, and hysteroscopy among others. It is often considered as an initial step to treat infertility and helps in comprehending the couple's medical history better, enabling customised treatment for their specific condition.

Global Fertility Test Market Analysis

The rising infertility rates, owing to the fast-paced and sedentary lifestyle, and increased drug indulgence, have contributed to the market growth in recent years. The rising emphasis on career often leads to delayed pregnancies and ends up contributing to the growing infertility rates. The rising incidence of diseases like PCOS, PCOD, endometriosis, varicocele, and azoospermia is a key factor aiding the fertility test market growth.

With increasing advancements in the medical ecosystem, fertility tests have evolved over the period. Everything from hormonal tests to imaging tests is available to the masses nowadays. Owing to the rising popularity of self-diagnostic tests and telemedicine, at-home fertility tests are the latest addition to the market. Rising initiatives by various leading companies and the government is also supporting the fertility test market demand.

To combat the rising burden of male infertility, researchers have been looking into new methods of diagnosis for effective treatments. In June 2023, scientists discovered two specific proteins, unique to viable sperm. These ASPX and AKAP4 proteins help in the analysis of whether surgery for non-obstructive azoospermia would be successful or not. This diagnostic test also aligns with the non-invasive approach and enables better decision-making in healthcare professionals.

Global Fertility Test Market Segmentation

Fertility Test Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Products

• Ovulation Predictor Kits
• Fertility Monitors
• Urine
• Saliva
• Blood

Market Breakup by Application

• Male
• Female

Market Breakup by End User

• Home Care
• Fertility Clinics
• Hospitals

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Fertility Test Market Overview

Infertility affects 1 in every 6 people on the planet. It is noteworthy that the high-income countries have a higher infertility prevalence (around 17.8%), than low- and middle-income countries where it is approximately 16.5%. Consequently, the North American region, particularly United States and Canada have led the fertility test market share in the historical period. The changing lifestyles, delayed pregnancies, and increased substance consumption have also contributed to the rising market size.

Europe also holds a significant part of the fertility tests market owing to the region's advanced healthcare system and rising awareness around fertility associated concerns spread by government as well as influential healthcare companies. The innovation and adoption of new technologies to combat the rising incidence of diseases such as PCOS, azoospermia, and endometriosis, among others is contributing to market growth.

Countries like China, Japan, India, and South Korea have been experiencing high growth in the market. Improving healthcare facilities, rising fertility awareness, evolving societal norms, and increasing disposable incomes are impacting the market value.

Global Fertility Test Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Swiss Precision Diagnostics
• Church & Dwight Co., Inc.
• Prestige Brands Holdings
• bioZhena
• Fairhaven Health
• Fertility Focus
• Geratherm Medical AG
• Hilin Life Products
• UEBE Medical
• Churchill Pharmaceuticals, LLC.
• Procter & Gamble Co.
• Mankind Pharma Ltd.
• Babystart Ltd.
• Innevation Pty Ltd.
• AdvaCare Pharma

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

This product will be delivered within 3-5 business days.